Viewing Study NCT05535218

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:46 AM

Ignite Modification Date: 2025-12-26 @ 3:48 AM

Study NCT ID: NCT05535218

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-04-02

First Post: 2022-08-09

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer

Sponsor: Claudia Guerrieri

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module